Sentinel Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-61,565
Closed -$3.95M 95
2018
Q4
$3.95M Sell
61,565
-8,778
-12% -$648K 1.22% 10
2018
Q3
$6.29M Sell
70,343
-23,405
-25% -$2.07M 1.37% 13
2018
Q2
$7.45M Buy
93,748
+16,428
+21% +$1.36M 1.66% 11
2018
Q1
$6.9M Buy
+77,320
New +$7.42M 1.46% 12
2017
Q4
Sell
-12,345
Closed -$1.8M 124
2017
Q3
$1.8M Buy
+12,345
New +$1.68M 0.3% 77
2017
Q1
Sell
-2,300
Closed -$266K 126
2016
Q4
$266K Hold
2,300
0.04% 111
2016
Q3
$240K Sell
2,300
-217
-9% -$23.5K 0.03% 113
2016
Q2
$248K Sell
2,517
-20
-0.8% -$2.07K 0.04% 121
2016
Q1
$254K Buy
2,537
+137
+6% +$14.1K 0.04% 119
2015
Q4
$287K Hold
2,400
0.04% 119
2015
Q3
$260K Sell
2,400
-124
-5% -$15.4K 0.04% 120
2015
Q2
$292K Hold
2,524
0.08% 129
2015
Q1
$291K Hold
2,524
0.08% 122
2014
Q4
$282K Hold
2,524
0.08% 119
2014
Q3
$239K Hold
2,524
0.06% 133
2014
Q2
$217K Buy
+2,524
New +$192K 0.06% 137
2014
Q1
Sell
-2,524
Closed -$213K 170
2013
Q4
$213K Buy
+2,524
New +$200K 0.06% 158

Other funds holding CELG

Sentinel Trust's CELG Position: Q1 2019 in Review

Sentinel Trust sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 61,565 shares — an estimated $3.95M sold.

Sentinel Trust first reported a position in CELG in Q4 2013 and held it in 17 quarters. The position peaked at $7.45M in Q2 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Sentinel Trust reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Sentinel Trust sold 61,565 Celgene Corp shares in Q1 2019, an estimated $3.95M.
  • Sentinel Trust first reported a position in Celgene Corp in Q4 2013 and held it in 17 quarters.
  • Sentinel Trust's Celgene Corp position peaked at $7.45M in Q2 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Sentinel Trust's 13F filing for Q1 2019, filed 15 May 2019.